The scientist’s investigation covers issues in Alzheimer's disease, Dementia, Pathology, Neuroscience and Internal medicine. His studies deal with areas such as Biomarker, Bioinformatics and Insulin resistance as well as Alzheimer's disease. His Dementia study is focused on Disease in general.
His work deals with themes such as Psychosis and Schizophrenia, which intersect with Neuroscience. He has included themes like Resting state fMRI, Endocrinology and Cardiology in his Internal medicine study. His study in Cognitive decline is interdisciplinary in nature, drawing from both Psychiatry, Gerontology, Cohort study and Risk factor.
His scientific interests lie mostly in Dementia, Disease, Neuroscience, Pathology and Alzheimer's disease. His Dementia research focuses on Cognition and how it relates to Clinical psychology. His work carried out in the field of Disease brings together such families of science as Clinical trial, Cerebrospinal fluid and Immunology.
Steven E. Arnold interconnects Schizophrenia, Psychosis and Neurodegeneration in the investigation of issues within Neuroscience. His Alzheimer's disease research is multidisciplinary, incorporating perspectives in Biomarker, Cohort and Degenerative disease. His studies in Internal medicine integrate themes in fields like Oncology and Cardiology.
His primary scientific interests are in Disease, Internal medicine, Dementia, Cerebrospinal fluid and Cognition. His Disease research is multidisciplinary, incorporating elements of Clinical study design and Cohort study. His Internal medicine study combines topics in areas such as Endocrinology, Neuroimaging, Oncology and Delirium.
His Dementia research incorporates elements of Cognitive test, Alzheimer's disease, Neuropathology, Neuroscience and Type 2 diabetes. His Alzheimer's disease research is multidisciplinary, incorporating perspectives in Epidemiology and Type 2 Diabetes Mellitus. His work is dedicated to discovering how Neuropathology, Diabetes mellitus are connected with Insulin and Pathology and other disciplines.
His primary areas of study are Disease, Alzheimer's disease, Dementia, Internal medicine and Biomarker. His Disease research is multidisciplinary, relying on both Computational biology and Lc ms ms. His studies deal with areas such as Common disease-common variant, Epidemiology and Diabetes mellitus, Type 2 Diabetes Mellitus, Insulin resistance as well as Alzheimer's disease.
Steven E. Arnold is studying Cognitive decline, which is a component of Dementia. His Internal medicine study integrates concerns from other disciplines, such as Positron emission tomography, Magnetic resonance imaging, Neuroimaging and Oncology. His Biomarker research includes elements of Hemoglobin, Cerebrospinal fluid and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease
S E Arnold;B T Hyman;J Flory;A R Damasio.
Cerebral Cortex (1991)
Common variants at MS4A4/MS4A6E , CD2AP , CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Konrad Talbot;Hoau-Yan Wang;Hala Kazi;Li-Ying Han.
Journal of Clinical Investigation (2012)
Loneliness and Risk of Alzheimer Disease
Robert S. Wilson;Kristin R. Krueger;Steven E. Arnold;Julie A. Schneider.
Archives of General Psychiatry (2007)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary;John Q. Trojanowski;Julie A. Schneider;Jose F. Abisambra.
Acta Neuropathologica (2014)
Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'
Peter Davies;Judith Resnick;Burton Resnick;Sid Gilman.
Neurobiology of Aging (1998)
Some Cytoarchitectural Abnormalities of the Entorhinal Cortex in Schizophrenia
steven E. Arnold;Bradley T. Hyman;Gary W. Van Hoesen;Antonio R. Damasio.
Archives of General Psychiatry (1991)
The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study
David A Bennett;Julie A Schneider;Yuxiao Tang;Steven E Arnold.
Lancet Neurology (2006)
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
Theresa R. Bomfim;Leticia Forny-Germano;Luciana B. Sathler;Jordano Brito-Moreira.
Journal of Clinical Investigation (2012)
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
H.I. Hurtig;J.Q. Trojanowski;J. Galvin;D. Ewbank.
Neurology (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Pennsylvania
University of Pennsylvania
Rush University Medical Center
University of Pennsylvania
Rush University Medical Center
University of Pennsylvania
University of Pennsylvania
University of Pennsylvania
Rush University Medical Center
University of Pennsylvania
University of Miami
Argonne National Laboratory
Vanderbilt University
Chinese Academy of Sciences
Chinese Academy of Sciences
Chinese Academy of Sciences
Sapienza University of Rome
University of Pittsburgh
China University of Geosciences
American Museum of Natural History
University of Alabama in Huntsville
Memorial Sloan Kettering Cancer Center
Utrecht University
Erasmus University Rotterdam
University of Cambridge
Stony Brook University